A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06415669 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric/Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Paclitaxel for injection (albumin-bound)
DRUG: Adebrelimab
DRUG: Apatinib mesylate

Sponsor

The First Affiliated Hospital of Xiamen University